Novo Holdings A/S

Q2 2024 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Barbara Fiorini Due - General Counsel
Location
Hellerup, Denmark
Holdings as of
June 30, 2024
Value $
$1.85B
Num holdings
38
Date filed
8/20/2024, 09:29 AM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q1 2024 - May 15, 2024
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q2 - Restatement compared to 2024 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Barbara Fiorini Due General Counsel Hellerup, Denmark 8/20/2024

Explanatory Note: This Amendment No. 1 restates the Form 13F Holdings Report filed by Novo Holdings A/S on August 14, 2024. This Amendment No. 1 (i) corrects data in the Information Table relating to the reported position in Evotec AG and Exscientia plc by removing the positions, (ii) corrects data in the Information Table relating to the reported position in Marqeta Inc by inserting 2419738 in Column 5 "VALUE" (iii) corrects data in the Information Table relating to the reported position in Viridian Therapeutics Inc by inserting 26020000 in Column 5 "VALUE", (iv) includes a position in Vanguard Index FDS, and (v) corrects the Report Summary by inserting $1,854,897,213 as the "Form 13F Information Table Values Total".